Quhill F, Beiderbeck A. Cost Advantage of Fluocinolone Acetonide Implant (ILUVIEN®) versus Ranibizumab in the Treatment of Chronic Diabetic Macular Oedema. Grhta [Internet]. 2017 Jul. 24 [cited 2024 Nov. 21];4(1):155-64. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/391